Mittie Doyle

Companies

• Cullinan OncologyBoard member Aug 8, 2025 to now¹
• Avalo Therapeutics, Inc.Chief Medical Officer Jul 16, 2024 to now²
• DICE Therapeutics, Inc.Board member Apr 1, 2022 to Aug 9, 2023³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ATAvalo Therapeutics, Inc. AVTX51,776 shares⁴$583.5K at $11.27Aug 28, 2026
• DTDICE Therapeutics, Inc.0 shares⁵Apr 1, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 28, 2026Sold 679 shares at $20.00 of Avalo Therapeutics, Inc.⁴
• Aug 28, 2026Exercised options 679 shares at $8.04 of Avalo Therapeutics, Inc.⁴
• Aug 17, 2026Sold 1,000 shares at $20.00 of Avalo Therapeutics, Inc.⁶
• Aug 17, 2026Exercised options 1,000 shares at $12.65 of Avalo Therapeutics, Inc.⁶
• Aug 10, 2026Sold 679 shares at $20.00 of Avalo Therapeutics, Inc.⁷
• Aug 10, 2026Exercised options 679 shares at $8.04 of Avalo Therapeutics, Inc.⁷
• Jul 27, 2026Sold 1,000 shares at $20.00 of Avalo Therapeutics, Inc.⁸
• Jul 27, 2026Exercised options 1,000 shares at $12.65 of Avalo Therapeutics, Inc.⁸
• Jun 30, 2026Sold 4,654 shares at $20.00 of Avalo Therapeutics, Inc.⁹
• Jun 30, 2026Exercised options 1,779 shares at $8.04 of Avalo Therapeutics, Inc.⁹
• Jun 30, 2026Exercised options 2,875 shares at $12.65 of Avalo Therapeutics, Inc.⁹
• Jun 23, 2026Sold 1,450 shares at $18.00 of Avalo Therapeutics, Inc.¹⁰
• Jun 23, 2026Exercised options 1,450 shares at $8.04 of Avalo Therapeutics, Inc.¹⁰
• Jun 10, 2026Shares withheld for tax 1,084 shares at $13.10 of Avalo Therapeutics, Inc.¹¹
• May 28, 2026Sold 679 shares at $16.00 of Avalo Therapeutics, Inc.¹²
• May 28, 2026Exercised options 679 shares at $8.04 of Avalo Therapeutics, Inc.¹²
• May 21, 2026Granted 43,500 shares of Avalo Therapeutics, Inc.¹³
• May 15, 2026Sold 3,000 shares at $18.76 of Avalo Therapeutics, Inc.¹⁴
• May 15, 2026Exercised options 3,000 shares at $12.65 of Avalo Therapeutics, Inc.¹⁴
• May 6, 2026Sold 10,058 shares at $22.88 of Avalo Therapeutics, Inc.¹⁵
• May 6, 2026Sold 19,015 shares at $22.41 of Avalo Therapeutics, Inc.¹⁵
• May 6, 2026Sold 44,944 shares at $21.20 of Avalo Therapeutics, Inc.¹⁵
• May 6, 2026Sold 5,000 shares at $19.65 of Avalo Therapeutics, Inc.¹⁵
• May 6, 2026Sold 27,538 shares at $18.03 of Avalo Therapeutics, Inc.¹⁵
• May 6, 2026Exercised options 28,650 shares at $8.04 of Avalo Therapeutics, Inc.¹⁵